Core Scientific, Inc.
CORZ
$14.53
$0.402.83%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.20M | 12.35M | 15.03M | 27.22M | 30.36M |
| Total Other Revenue | 62.42M | 67.18M | 79.90M | 68.14M | 110.74M |
| Total Revenue | 78.63M | 79.53M | 94.93M | 95.35M | 141.10M |
| Cost of Revenue | 73.60M | 71.31M | 85.86M | 90.68M | 102.29M |
| Gross Profit | 5.03M | 8.21M | 9.06M | 4.68M | 38.82M |
| SG&A Expenses | 56.94M | 40.12M | 42.88M | 42.34M | 31.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -29.80M | 10.69M | 805.00K | 206.00K | 584.00K |
| Total Operating Expenses | 100.75M | 122.12M | 134.56M | 136.06M | 134.25M |
| Operating Income | -22.12M | -42.59M | -39.63M | -40.71M | 6.85M |
| Income Before Tax | -936.64M | 580.90M | -265.17M | -455.13M | -804.75M |
| Income Tax Expenses | 158.00K | 205.00K | 375.00K | 134.00K | 144.00K |
| Earnings from Continuing Operations | -936.80M | 580.69M | -265.54M | -455.26M | -804.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -936.80M | 580.69M | -265.54M | -455.26M | -804.90M |
| EBIT | -22.12M | -42.59M | -39.63M | -40.71M | 6.85M |
| EBITDA | -3.36M | -22.86M | -13.59M | -12.02M | 36.33M |
| EPS Basic | -0.04 | -0.17 | -0.60 | -1.17 | -4.51 |
| Normalized Basic EPS | -1.83 | 1.15 | -0.55 | -0.97 | -2.82 |
| EPS Diluted | -0.04 | -0.17 | -0.60 | -1.17 | -4.51 |
| Normalized Diluted EPS | -1.83 | 1.15 | -0.55 | -0.97 | -2.82 |
| Average Basic Shares Outstanding | 317.99M | 315.20M | 306.15M | 292.49M | 178.51M |
| Average Diluted Shares Outstanding | 317.99M | 315.20M | 306.15M | 292.49M | 178.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |